Viewing Study NCT02435927


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT02435927
Status: UNKNOWN
Last Update Posted: 2021-04-28
First Post: 2015-04-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
Sponsor: National Cancer Centre, Singapore
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module